Aerosol droplet formation during HFNC treatment * risk assessment for SARS-CoV-2 transmission to health care workers

Completed

• Conditions: COVID-19; hypoxemia; 10024970

• Registration Number: NL-OMON49784
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 6

Inclusion Criteria

Healthy volunteers

Exclusion Criteria

Chronic respiratory diseases, fever or upper respiratory disease symptoms in
the last 2 weeks prior to participation

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Aerosol droplet formation (quantification per surface area) and travel<br /><br>velocity.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p><br>